logo

For the Inventor, By the Inventor

Park Ridge, NJ, United States of America

Sow-Mei L Chen

This inventor holds 22 USPTO granted patents, primarily in Prostanoid Chemistry. Top assignee: American Cyanamid Company. Active years: 1980-1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sow-Mei L Chen. Retrieved from https://idiyas.com/inventor/sow-mei-l-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22

% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 3

Forward Citations = 34(Granted Patents)


Company Filing History:

goldMedal21 out of 3,580 
 
American Cyanamid Company
 patents
where one patent can have more than one assignee

Years Active: 1980-1988

Loading Chart...
Areas of Expertise:
Prostanoic Acids
Prostacyclin Analogs
Vinylstannyl Derivatives
Ethynyl Substituted
Cyclopropyl Substituted
Fluoromethyl Derivatives
Chloromethyl Prostaglandins
Iodo-Prostacyclin
Carboxy Derivatives
Hydroxy Compounds
22 patents (USPTO):Explore Patents
1. 4730065 - 15-deoxy-16-hydroxy-16-substituted prostanoic acids and congeners (1988-03-08),
2. 4518790 - 15-Deoxy-16-hydroxy-16-vinyl and cyclopropyl substituted prostanoic (1985-05-21),
3. 4504417 - 15-Deoxy-16-hydroxy-16-substituted prostanoic acids and congeners (1985-03-12),
4. 4477388 - Vinylstannyl derivatives (1984-10-16),
5. T103403 - 15-Deoxy-16-hydroxy-16-vinyl and cyclopropyl substituted prostanoic (1983-09-05),
6. 4390711 - 16-Hydroxy-5-iodo-prostacyclin analogs of the 1 series (1983-06-28),
7. 4358605 - 15-Deoxy-16-hydroxy-16-vinyl and cyclopropyl substituted prostanoic (1982-11-09),
8. 4328358 - 15-Deoxy-16-hydroxy-16-substituted prostanoic acids and congeners (1982-05-04),
9. 4265904 - Prostacyclin analogs of the 1 series and related analogs (1981-05-05),
10. 4250325 - Novel 15-deoxy-16-ethynyl and -16-(1-propynyl)-1-carboxy and 1-carbinol (1981-02-10),
11. 4239900 - Various 15-deoxy-16-hydroxy-16-ethynyl and 16-ethynylsubstituted (1980-12-16),
12. 4239899 - Various 15-deoxy-16-hydroxy-16-ethynyl and 16-ethynylsubstituted (1980-12-16),
13. 4235924 - Prostacyclin analogs of the 1 series and related analogs wherein the (1980-11-25),
14. 4233231 - Novel vinyl-stannyl derivatives (1980-11-11),
15. 4228298 - 15-Deoxy-16-hydroxy-16-fluoromethyl, difluoromethyl or trifluoromethyl (1980-10-14),

Title: The Innovative Contributions of Sow-Mei L Chen in the Field of Prostaglandins

Introduction: Sow-Mei L Chen is an accomplished inventor based in Park Ridge, NJ, with a significant portfolio of 22 patents. His work primarily focuses on novel prostanoic acids, showcasing his dedication to advancing medical treatments and improving healthcare.

Latest Patents: Among his latest patents are the creations of 15-deoxy-16-hydroxy-16-substituted prostanoic acids and congeners. This innovation has been recognized for its utility as bronchodilators, hypotensive agents, and for controlling excessive gastric secretion. Additionally, he has developed 15-deoxy-16-hydroxy-16-vinyl and cyclopropyl substituted prostanoic acids, which also serve therapeutic purposes and include variations like the methyl ester of such acids.

Career Highlights: Sow-Mei L Chen's career has been marked by his contributions to the American Cyanamid Company, where he has been instrumental in research and development efforts. His extensive knowledge in medicinal chemistry has significantly impacted the formulation of new pharmaceuticals.

Collaborations: Throughout his career, Sow-Mei has collaborated with notable coworkers such as Charles V Grudzinskas and Middleton B Floyd, Jr. These partnerships have fostered an environment of innovation and creativity, allowing for the cross-pollination of ideas and expertise.

Conclusion: Sow-Mei L Chen's contributions to the field of prostaglandins exemplify his commitment to scientific innovation and healthcare improvement. His patented inventions not only highlight his ingenuity but also reflect the collaborative spirit of the research community he is part of. As the medical landscape continues to evolve, Chen's work stands as a testament to the power of inventiveness in addressing pressing health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…